Table 3.
Characteristics of the 3 groups by PFMTa adherence level.
| Characteristic | PFMT adherence level | P value | ||||
|
|
High (n=7) | Moderate (n=3) | Low (n=7) |
|
||
| UIb at baseline (n=1), n (%) | 0 (0) | 0 (0) | 1 (100) | .99c | ||
| Age (years), median (IQR) | 34 (32-36) | 41 (37-42) | 33 (30-36) | .03d | ||
| Multipara (n=14), n (%) | 6 (43) | 2 (14) | 6 (43) | .99c | ||
| BMI before pregnancy (kg/m2), median (IQR) | 21 (19-25) | 20 (19-21) | 18 (17-20) | .07d | ||
| Weight gain during pregnancy (kg), median (IQR) | 12 (10-13) | 10 (6-16) | 10 (8-10) | .35d | ||
| Child’s birth weight (g), median (IQR) | 3213 (3060-3530) | 2722 (2704-2885) | 2752 (2675-2932) | .01d | ||
| Weekly mean number of PFMCse performed per day (times), median (IQR) | ||||||
|
|
Week 1 | 18 (17-18) | 11 (5-12) | 3 (2-7) | .004d | |
|
|
Week 2 | 17 (15-18) | 13 (8-15) | 2 (2-4) | .003d | |
|
|
Week 3 | 18 (17-18) | 11 (9-15) | 2 (4-1) | .001d | |
|
|
Week 4 | 18 (17-18) | 9 (8-18) | 2 (1-3) | .002d | |
|
|
Week 5 | 18 (18-18) | 15 (7-15) | 2 (1-3) | .001d | |
|
|
Week 6 | 18 (14-18) | 8 (6-15) | 2 (1-3) | .001d | |
|
|
Week 7 | 18 (17-18) | 9 (6-14) | 1 (1-3) | <.001d | |
|
|
Week 8 | 18 (18-18) | 7 (5-8) | 2 (1-3) | .001d | |
|
|
Total PGHDf (times) | 53 (43-56) | 54 (46-54) | 52 (40-54) | .64d | |
| “Was it difficult to record the PFMCs every day?” (n=12), n (%) | .17c | |||||
|
|
“Strongly agree” and “Agree a little” (n=1) | 0 (0) | 1 (100) | 0 (0) |
|
|
|
|
“Neither agree nor disagree,” “Disagree a little,” and “Strongly disagree” (n=11) | 4 (36) | 1 (9) | 6 (54) |
|
|
aPFMT: pelvic floor muscle training.
bUI: urinary incontinence.
cFisher exact test.
dMann-Whitney U test.
ePFMC: pelvic floor muscle contraction.
fPGHD: patient-generated health data.